Table 2 gabarapl1 expression in relation to the usual prognostic factors

From: High expression of gabarapl1 is associated with a better outcome for patients with lymph node-positive breast cancer

 

All patients

pN0 patients

pN+ patients

 

N =265

N =126

N =139

Characteristics

n

Median

P- value

n

Median

P- value

n

Median

P- value

Surgical tumour size

 pT1

114

5.41

 

70

5.85

 

44

4.90

 

pT2

139

3.90

 

52

4.68

 

87

3.55

 

 ND

12

 

<0.001

4

 

0.212

8

 

0.013

Histological type

 Ductal

216

4.34

 

99

5.23

 

117

3.90

 

 Lobular

39

5.34

 

18

6.27

 

21

4.71

 

 Others

10

 

0.076

9

 

0.218

1

 

0.231

Histological grade a

 1

31

5.52

 

17

5.52

 

14

5.48

 

 2

114

4.96

 

58

6.12

 

56

4.33

 

 3

57

2.96

 

22

2.95

 

35

3.09

 

 ND

14

 

<0.001

2

 

<0.001

12

 

<0.001

Node status

         

 pN0

126

5.55

       

 pN+

139

4.01

<0.001

      

ER and PgR status

 ER and PgR positive

191

5.08

 

97

6.07

 

94

4.50

 

 ER and/or PgR negative

74

3.24

<0.001

29

3.28

0.002

45

3.21

0.002

  1. aHistological grade defined only in ductal carcinoma.
  2. P-values correspond to Mann–Whitney test or Kruskall–Wallis test (histological grade).